CellCentric

Bioscience & Disease Healthcare Systems

@CellCentric Website LinkedIn Cambridge, UK

About CellCentric

CellCentric is a biotech company focused on advancing inobrodib in multiple myeloma trials. The company aims to develop innovative therapies for hematological malignancies, particularly targeting relapsed or refractory multiple myeloma.

Business Information

Target Customers

pharmaceutical companies healthcare providers research institutions

Industry Categories

Bioscience & Disease Healthcare Systems

Business Model

Revenue Model Biopharmaceutical development

Pricing Strategy N/A

Sales Channels partnerships with pharmaceutical companies, clinical trial collaborations

Funding Timeline

Round	Date	Amount	Investors
Series C	May 19, 2025	$120.0M	Pfizer

Founders

No founder information available.

Investors

Pfizer

Corporate Venture Capital

Recent Mentions

BioTech Visionary @BioTechVisions

May 19, 2025

🚨 Pfizer-Backed CellCentric Secures $120M to Advance Inobrodib in Multiple Myeloma Trials 🚨 CellCentric, a Cambridge, U.K.-based biotech company, has raised $120 million in a Series C funding round to propel its lead candidate, inobrodib, into pivotal trials for relapsed or https://t.co/FXPhWeGtTK

View on Twitter

Raising.fi @raisingfi

May 19, 2025

New Raise 🏛️ Company: CellCentric 🔗 Website: https://t.co/aNMUUxDCyR 📊 Amount: $120 Million 🔄 Round: Series C 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare

View on Twitter

Similar Startups

Tcelltech

88% match

Tcelltech is a clinical-stage biopharma focused on developing immunotherapies.

BillionToOneInc

85% match

A biotech company focused on diagnostics, specializing in innovative solutions for genetic testing a...

One Biosciences

85% match

One Biosciences is a biotechnology company focused on innovative solutions in the life sciences sect...

BioTroy Therapeutics

85% match

BioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...